A

Anchiano Therapeutics

2 employees

Anchiano is a clinical-stage biopharmaceutical company focused on the discovery and development of novel therapies to treat cancer.

Basic info

biotechnology research

Biotechnology

Gene Therapy

immunotherapy

RAS

Cancer

Medical Device

Target Therapy

Health Care

Oncology

Pan-RAS

Bladder Cancer

2004

$23M

from 2 investors over 2 rounds

A

Anchiano Therapeutics raised $23M on April 13, 2018

Investors: Clal Biotechnology Industries

A

Anchiano Therapeutics raised undisclosed on March 1, 2010

Investors: Cybele Holdings